Results 21 to 30 of about 132,846 (252)

Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases

open access: yesFrontiers in Immunology, 2018
The complement system has moved into the focus of drug development efforts in the last decade, since its inappropriate or uncontrolled activation has been recognized in many diseases.
József Dobó   +2 more
doaj   +1 more source

Mathematical Modelling of Alternative Pathway of Complement System [PDF]

open access: yesBulletin of Mathematical Biology, 2020
Abstract The complement system (CS) is an integral part of innate immunity and can be activated via three different pathways. The alternative pathway (AP) has a central role in the function of the CS. The AP of complement system is implicated in several human disease pathologies.
Suruchi Bakshi   +10 more
openaire   +2 more sources

Comparison of dominant and nondominant C3 deposition in primary glomerulonephritis [PDF]

open access: yesKidney Research and Clinical Practice, 2023
Background Alternative complement pathway dysregulation plays a key role in glomerulonephritis (GN) and is associated with C3 deposition. Herein, we examined pathological and clinical differences between cases of primary GN with C3-dominant (C3D-GN) and ...
Jiwon Ryu   +14 more
doaj   +1 more source

Complement-coagulation cross-talk: a potential mediator of the physiological activation of complement by low pH

open access: yesFrontiers in Immunology, 2015
The complement system is a major constituent of the innate immune system. It not only bridges innate and adaptive arms of the immune system but also links the immune system with the coagulation system.
Hany Ibrahim Kenawy   +2 more
doaj   +1 more source

Quantitative Modeling of the Alternative Pathway of the Complement System. [PDF]

open access: yesPLoS ONE, 2016
The complement system is an integral part of innate immunity that detects and eliminates invading pathogens through a cascade of reactions. The destructive effects of the complement activation on host cells are inhibited through versatile regulators that
Nehemiah Zewde   +3 more
doaj   +1 more source

Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation

open access: yesFrontiers in Immunology, 2022
ObjectiveThe pathogenesis of thrombotic microangiopathy (TMA) in lupus nephritis (LN) remains complicated. This study aimed to detect the deposition of complement lectin pathway (LP) and alternative pathway (AP) components in renal tissues, then evaluate
Binshan Zhang, Guolan Xing
doaj   +1 more source

The Alternative Pathway of Complement Activation in the Neonate [PDF]

open access: yesPediatric Research, 1975
C3PA (factor B) concentrations taken as an indication of alternate pathway development for neonates and adults were compared. The mean level for umbilical cord sera was 39 +/- 2%, with a range of 19.5-77.5%. The normal adult mean level was 74 +/- 4%, with a range of 43-108%. The difference between the two is highly significant (P less than 0.001).
P A, Feinstein, S R, Kaplan
openaire   +2 more sources

Alternative complement pathway deregulation is correlated with dengue severity. [PDF]

open access: yesPLoS ONE, 2009
BACKGROUND:The complement system, a key component that links the innate and adaptive immune responses, has three pathways: the classical, lectin, and alternative pathways. In the present study, we have analyzed the levels of various complement components
Eduardo J M Nascimento   +6 more
doaj   +1 more source

The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy

open access: yesFrontiers in Immunology, 2019
IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide and a common cause of end-stage renal disease. Evaluation of a kidney biopsy is necessary for diagnosis, with routine immunofluorescence microscopy revealing dominant ...
Dana V. Rizk   +7 more
doaj   +1 more source

Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway [PDF]

open access: yesThe Journal of Experimental Medicine, 2001
We studied complement 1 inhibitor (C1-INH) as an inhibitor of the alternative complement pathway. C1-INH prevented lysis, induced by the alternative complement pathway, of paroxysmal nocturnal hemoglobinuria (PNH) erythrocytes in human serum. It inhibited the binding of both factors B and C3 to PNH and rabbit erythrocytes and blocked the ability of ...
H, Jiang   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy